Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

BACKGROUND: Adjuvant endocrine therapy undoubtedly prolongs the time to recurrence for patients with hormone-positive early breast cancer. Extended endocrine therapy to 10 years or longer has been expected to bring a greater clinical advantage. However, the related research conclusions are controver...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Chang, Bingmei, Jiang, Xiaoyue, Fan, Xueke, Li, Yingrui, Li, Teng, Wu, Shanshan, Zhang, Jun, Kariminia, Seyed, Li, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186070/
https://www.ncbi.nlm.nih.gov/pubmed/30314452
http://dx.doi.org/10.1186/s12885-018-4878-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186070/
https://www.ncbi.nlm.nih.gov/pubmed/30314452
http://dx.doi.org/10.1186/s12885-018-4878-4

Ejemplares similares